CompletedNot Applicable

Innovative Support for Patients With SARS-COV2 Infections (COVID-19) Registry (INSPIRE)

United States6,000 participantsStarted 2020-12-15

Plain-language summary

The Innovative Support for Patients with SARS COV-2 Infections Registry (INSPIRE) study is a CDC-funded COVID-19 project to understand the long-term health outcomes in recently tested adults, both negative and positive, who have suspected COVID symptoms at the time of their test. Participants will complete short online surveys every 3 months for 18 months, share information about their health using a secure web-based platform, and are compensated for their time.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Fluent in English or Spanish;
✓. Age 18 and over;
✓. Self-reported symptoms suggestive of acute SARSCOV2 infection;
✓. Under investigation for SARSCOV2 (defined as a patient who has received any screening or diagnostic test used to detect the presence of COVID19 including any FDA approved or authorized molecular or antigen-based assay) within the last 42 days.

Exclusion criteria

✕. Unable to provide informed consent;
✕. Study team unable to confirm result of diagnostic test for SARSCOV2;
✕. Does not have access to a hand-held device or computer that would allow for digital participation in the study;
✕. Individuals who are prisoners while participating in the study.

What they're measuring

Assess for medium and long-term sequalae of SARS-CoV-2 infection

Timeframe: 18 months post enrollment

Trial details

NCT IDNCT04610515

SponsorRush University Medical Center

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-08-31

View on ClinicalTrials.gov More Covid19 trials